Obesity is associated with structural and functional changes in perivascular adipose tissue (PVAT), favouring release of reactive oxygen species (ROS), vasoconstrictor and proinflammatory factors. The cytokine TNF-α induces vascular dysfunction and is produced by PVAT. We tested the hypothesis that obesity-associated PVAT dysfunction was mediated by augmented mitochondrial ROS (mROS) generation due to increased TNF-α production in this tissue.
Introduction
The perivascular adipose tissue (PVAT) releases a wide range of adipokines, vasoactive and inflammatory mediators that influence vascular function in a paracrine manner (Gollasch and Dubrovska, 2004; Szasz et al., 2013) . Obesity is frequently associated with structural and functional alterations in PVAT, leading to dysfunction of vascular endothelium and smooth muscle, and increased overall cardiovascular risk. The proposed mechanisms include impaired anti-contractile function, perivascular inflammation via production of pro-inflammatory cytokines and chemokines and the accumulation of macrophages, as well as dysregulation of adipocyte-derived adipokines (Guzik et al., 2007; Ketonen et al., 2010; Fernández-Alfonso et al., 2013; Sun et al., 2013) . TNF-α, which plays a critical role in the development of vascular dysfunction, insulin resistance, inflammation and atherosclerosis, is produced by the PVAT (Omar et al., 2014; Virdis et al., 2015; da Costa et al., 2016) . TNF-α also induces adipocyte dysfunction, leading to a vicious circle between adipocytes and macrophages, which may aggravate inflammatory changes in PVAT (Takaoka et al., 2010; Oriowo, 2015) . Therefore, TNF-α-induced PVAT dysfunction may represent a major mechanism whereby this cytokine exerts a deleterious role on vascular function.
The structural and physiological characteristics of PVAT vary in each vascular territory. In the mesenteric bed, PVAT resembles the white adipose tissue showing less differentiated adipocytes with low vascularization and metabolism (Fitzgibbons et al., 2011) . However, the morphological characteristics of aortic PVAT are very similar to that of brown adipose tissue (BAT), with small, multilocular lipid droplets and abundant mitochondria in the adipocytes. The similarities extend to the transcriptional profile as well, with close gene expression overlapping between BAT and PVAT, including expression of uncoupling protein 1 (UCP-1), important in thermogenesis (Fitzgibbons et al., 2011; Padilla et al., 2013) . Increased thermogenic activity of PVAT is associated with improved endothelial function and protection from vascular disease, which implies that PVAT itself may influence thermogenesis, with immediate translation into vascular activity (Chang et al., 2012) .
Mitochondria are critical regulators of cell death, calcium signalling, generation and disposal of ROS. We have recently shown that ROS generated from the mitochondrial metabolism mediates PVAT anti-contractile effects . Consistent with this concept, mitochondrial dysfunction in adipocytes of obese patients increases pro-oxidative status via generation of ROS, thereby compromising tissue homeostasis (Medina-Gomez, 2012) . Whether mitochondrial ROS (mROS) in the PVAT leads to loss of its modulatory effects on the vasculature is unclear. In the present study, we tested the hypothesis that obesity induced by a high-fat diet (HFD) impaired mitochondrial function in the PVAT, leading to increased generation of mROS and loss of the anti-contractile effects of PVAT. We also determined the specific role of TNF-α on mROS generation in PVAT from obese animals.
Methods

Animals and diets
All animal care and experimental protocols were performed in accordance with the Conselho Nacional de Controle de Experimentação Animal and were approved by the Ethics Committee on Animal Use of the University of Sao Paulo, Ribeirao Preto, Brazil (Protocol no. 149/2014) . Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) .
Five-week-old, male, C57Bl/6 J and TNF-α receptordeficient mice (TNF KO) 
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light/dark cycles under controlled temperature (22 AE 1°C) with ad libitum access to food and water. After a 1 week acclimatization period, mice were divided into two groups: 1) mice maintained on a control diet (protein 22%, carbohydrate 70% and fat 8% of energy, PragSolucoes, Jau, Brazil); 2) mice receiving an HFD (protein 10%, carbohydrate 25% and fat 65% of energy, PragSolucoes) for 18 weeks. After the treatment period, mice were killed by carbon dioxide (CO 2 ) inhalation.
Nutritional and metabolic profile of high-fat diet-induced obese mice
The nutritional profile of the animals was determined weekly by analysis of the caloric intake, feed efficiency, body weight and body fat. Caloric intake (per mouse) was calculated from the weekly food intake multiplied by the dietary energetic value. Feeding efficiency and the ability to transform consumed calories into body weight were determined with the formula: mean body weight gain (g)/total calorie intake. Animal body weight was measured weekly and obesity was defined using the adiposity index {[body fat (g)/final body weight (g)] × 100}. Body fat was calculated by the sum of the epididymal, retroperitoneal and visceral fats (Taylor and Phillips, 1996) . After 18 weeks of HFD, glucose concentrations were determined in serum samples from mice fasted for 12 h, by an enzymic colorimetric glucose oxidase method (Doles®).
Assessment of vascular function
The thoracic aorta was rapidly removed, transferred to an icecold (4°C) modified Krebs-Henseleit solution (composition in mM: 130 NaCl, 14.9 NaHCO 3 , 4.7 KCl, 1.18 KH 2 PO 4 , 1.17 MgSO 4 ·, 5.5 glucose, 1.56 CaCl 2 ·and 0.026 EDTA) gassed with 5% CO 2 : 95% O 2 to maintain a pH of 7.4 and dissected into 2 mm rings whereby perivascular fat and connective tissues were either removed (PVATÀ) or left intact (PVAT+). Aortic rings were mounted in a wire myograph to measure isometric tension, as previously described (Lobato et al., 2012) . Vessels were allowed to equilibrate for about 30 min in the Krebs-Henseleit solution.
After the stabilization period, endothelial function was assessed by testing the relaxant effect of ACh (10 À6 M) on vessels contracted with phenylephrine (10 À7 M). Aortic rings exhibiting a vasodilator response to ACh greater than 80% were considered endothelium-intact vessels. In experiments with endotheliumdenuded vessels, aortic rings were subjected to rubbing of the intimal surface. Rings showing a maximum of 5% relaxation in response to ACh were considered to be without endothelium. Cumulative concentration-response curves to phenylephrine (10
À10
-10 À4 M) and the Rho kinase inhibitor Y27632
(10
-10 À4 M) were performed in PVAT+ or PVATÀ aortic rings.
Contractile responses to phenylephrine were also determined after incubation with the selective superoxide anion (O 2 .- 
Measurement of ROS in PVAT
Dihydroethidium. ROS generation in PVAT was assessed by dihydroethidium (DHE), as previously described (Suzuki et al., 1995) . Aortas surrounded by periaortic fat were embedded in medium for frozen tissue specimens to ensure optimal cutting temperature (OCT ™ ) and stored at À80°C.
Fresh-frozen specimens were cross sectioned at 10 μm thickness and placed on slides covered with poly-(L-lysine) solution. Determination of superoxide dismutase and catalase activity in PVAT PVAT was isolated from thoracic aorta, homogenized in 300 μL PBS (pH 7.4) and centrifuged at 5000 x g (15 min, 4°C). The supernatant was used to analyse superoxide dismutase (SOD) activity (SigmaAldrich, St. Louis, MO, USA). PVAT catalase activity was assayed by H 2 O 2 consumption. PVAT was homogenized in PBS as previously described (Gonzaga et al., 2014) . Reaction buffer was added to quartz cuvettes containing 20 μL of the supernatant. The absorbance was read for 1 min at 240 nm. One catalase unit (U) was defined as the amount of enzyme required to decompose 1 μmol of H 2 O 2 ·min À1 . albumin, pH 7.1). PVAT respiration was monitored in MiR05 solution containing respiratory substrates (5.2 mM succinate, 4.5 mM pyruvate, 2.5 mM malate and 2.5 mM glutamate) at 37°C using the OROBOROS High Resolution Oxygraph (Austria) equipped with the DataLab 5.0 software (Dechandt, et al., 2016) .
Mitochondrial respiration in PVAT
Quantitative real-time RT-PCR)
Total RNA was isolated from PVAT using Trizol® (Invitrogen). RNA was treated with DNAse I (1 U·μL À1 , Promega) and used for first-strand cDNA synthesis, accordingly to the manufacturer instructions. mRNA levels were quantified in triplicate by qPCR StepOnePlus ™ Life Technologies. Specific primers (TaqMan ™ ) for RT-qPCR were as follows: mouse TNF
[Mm00443260_g1] and β-actin [Mm00607939_s1], purchased from Life Technologies. PCR cycling conditions included 10 min at 95°C, followed by 40 cycles at 95°C for 15 s, 60°C for 1 min and 72°C for 60 s. Dissociation curve analysis confirmed that signals corresponded to unique amplicons. Specific mRNA expression levels were normalized relative to β-actin mRNA levels using the comparative 2 -ΔΔCt method.
Western blot analysis
PVAT isolated from aortas was frozen in liquid nitrogen and homogenized in a lysis buffer (50 mM Tris/HCl, 150 mM NaCl, 1% Nonidet P40, 1 mM EDTA, 1 μg·mL À1 leupeptin, 1 μg·mL À1 pepstatin, 1 μg·mL À1 aprotinin, 1 mM sodium orthovanadate, 1 mM PMSF and 1 mM sodium fluoride). The tissue extracts were centrifuged, and total protein content was quantified using the Bradford method (Bradford, 1976) . Proteins (60 μg) were separated by electrophoresis on 10% polyacrylamide gel and transferred on to nitrocellulose membranes. Non-specific binding sites were blocked with 5% BSA in TBS containing 0.1% Tween 20 (for 1 h at 24°C). Membranes were incubated with antibodies (at the indicated dilutions) overnight at 4°C. Antibodies were used as follows: anti-MnSOD (1:1000 dilution; Millipore), anti-catalase (1:500 dilution; Cell Signaling Technology), anti-MYPT-1 (1:400 dilution; Cell Signaling Technology), antipMYPT-1 Thr 853 (1:400 dilution; Cell Signaling Technology)
anti-UCP-1 (1:1000 dilution; Cell Signaling Technology) and anti-β-actin (1:3000 dilution; Abcam). After incubation with secondary antibodies, signals were obtained by chemiluminescence, visualized by autoradiography and quantified densitometrically.
Assessment of Rho kinase activity
Rho kinase activity was determined by ELISA with a Rho kinase activity assay kit (Cell Biolabs).
Data and statistical analyses
The data and statistical analysis in this study comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Data are presented as mean AE SEM; n represents the number of animals used. Contractions to phenylephrine are expressed as tension changes (mN) in the displacement from baseline. The individual concentration-response curves were fitted into a curve by nonlinear regression analysis. pD 2 (defined as the negative logarithm of the EC 50 values) and maximal response (Emax) were compared by Student's t-test or two-way ANOVA with Bonferroni post test, as appropriate. The Prism software, version 5.0 (GraphPad Software Inc., San Diego, CA, USA), was used to analyse these parameters as well as to fit the sigmoidal curves. P values less than 0.05 were considered significant.
Materials
Phenylephrine, ACh, Y27632, PEG-catalase, MnTMPyP and tiron were purchased from Sigma Chemical Co (St. Louis, MO). CCCP and recombinant TNF-α were purchased from R&D Systems, Inc. (Minneapolis, MN). Infliximab (Remicade ®) was purchased from Janssen Biologics.
Results
Increased ROS generation in PVAT from obese mice impairs PVAT modulation of vascular contraction
After 18 weeks on the HFD, there was a marked increase in nutritional and anthropometric parameters in the obese mice, compared with mice on the control diet (Table S1 ). To investigate whether HFD-induced obesity impaired modulation of aortic contractions by PVAT, aortic rings with or without PVAT were exposed to the vasoconstrictor phenylephrine in a concentration-dependent manner. Aortic rings with PVAT from HFD-fed mice displayed higher maximal contractions and increased pD 2 values to phenylephrine, compared with rings from control mice ( Figure 1A , Table S3 ). Removal of PVAT increased contractions to phenylephrine only in control mice and resulted in maximal contractions that were not significantly different between the groups ( Figure 1A ). To investigate whether increased contractions to phenylephrine in PVAT-intact aortas of HFD-fed mice were due to reduced release of endothelium-dependent relaxing factors, responses to phenylephrine were also induced in endotheliumdenuded (with or without PVAT) aortic rings. Absence of the endothelium increased contractions to phenylephrine . However, aortic rings with PVAT from HFD-fed mice still exhibited increased phenylephrine-induced contractions when compared with the control group ( Figure 1B) , suggesting that the loss of the anti-contractile effects of PVAT in obesity is for the most part endothelium-independent.
We next determined whether increased ROS generation in PVAT directly mediated the effects of HFD on the anticontractile effects of PVAT. Inactivation of O 2 .-by the superoxide scavenger tiron (10 À4 M) significantly decreased phenylephrine-induced contractions in PVAT (À) aortic rings from control mice, whereas contractile responses in PVAT (+) rings were increased ( Figure 1C ). Tiron decreased BJP R M da Costa et al.
phenylephrine-induced contractions in PVAT (+) aortic rings from HFD-fed mice ( Figure 1D ). These findings suggest that obesity induces a significant increase in ROS generation that contributes to the loss of the anti-contractile effects of PVAT. Consistent with these observations, basal levels of ROS, determined by DHE fluorescence intensity ( Figure 1E ) and lucigenin-derived luminescence ( Figure 1F ), were significantly increased in PVAT from HFD-fed mice compared with PVAT from control animals.
Mitochondria-derived ROS in PVAT mediate the increased phenylephrine-induced vasoconstriction in obese mice
In order to assess whether obesity impaired mitochondrial function and increased O 2 ·-production in PVAT, we used the membrane permeant Mn-SOD mimetic MnTMPyP (3 × 10 À5 M) (Liang et al., 2009) . PVAT (+) aortic rings from control mice displayed decreased contractile response to phenylephrine in the presence of MnTMPyP (Figure 2A ),
Figure 1
Increased superoxide anion generation contributes to the loss of the anti-contractile effects of PVAT in HFD obesity. Concentration-effect curves to phenylephrine (PE) were performed in endothelium-intact [(A) n = 6 for each experimental group] and endothelium-denuded [(B) n = 7 for each experimental group] aortic rings with or without PVAT. The role of ROS on PVAT modulation of aortic smooth muscle contraction was investigated using tiron (10 À4 M), an O 2 .-scavenger in endothelium-denuded aortic rings from control [(C) n = 7 for each experimental group] and obese [(D) n = 7 for each experimental group] mice. ROS generation in PVAT was measured ( E) by DHE and (F) by lucigenin (n = 8 in all groups) in control and obese mice. Results represent the mean AE SEM. * P < 0.05 versus Control PVAT (À); # P < 0.05 versus Control PVAT (+); & P < 0.05 versus Obese PVAT (+); π P < 0.05 versus Control.
Figure 2
Mitochondria are a potential source of increased ROS in PVAT from obese mice, and mitochondria-derived ROS alter the expression of antioxidant enzymes in PVAT. Concentration-effect curves to PE were performed in endothelium-denuded aortic rings from control [(A and C) n = 8 for each experimental group] and obese [(B and D) n = 8 for each experimental group] mice. The role of mROS on PVAT modulation of aortic smooth muscle contraction was investigated using MnTMPyP (3 × 10 À5 M), a mitochondria-targeted superoxide scavenger and PEG-catalase (Peg-cat; Figure 2B ). Indeed, the presence of PEGcatalase(200 U·mL À1 ), which is rapidly transported to the intracellular space and participates in the dismutation of mitochondria-derived H 2 O 2 , increased the contractile response to phenylephrine in PVAT (+) aortae from control mice ( Figure 2C ). By contrast, PVAT (À) and PVAT (+) aortic rings from obese mice displayed decreased contractile responses to phenylephrine in the presence of PEG-catalase ( Figure 2D ), suggesting that H 2 O 2 is a contractile factor in obesity. Consistent with the idea that PVAT-derived ROS modulate vascular reactivity, expression of the Mn-SOD isoform was significantly reduced ( Figure 2E ) whereas catalase expression was increased in PVAT from obese mice ( Figure 2F ). Obesity increased SOD activity ( Figure 2G ) but did not change catalase activity ( Figure 2H ) in PVAT. These data suggest a compensatory mechanism for increased ROS in PVAT from obese mice.
Impaired mitochondrial function mediates the increased ROS generation and loss of the anti-contractile effects of PVAT in HFD-treated obese mice
We examined whether mitochondrial coupling, in turn, promotes ROS generation and the subsequent loss of the anticontractile effects of PVAT in HFD-fed mice. Analysis of mitochondrial respiration in PVAT from HFD-fed mice revealed a severe decrease in O 2 consumption rates in both ROUTINE (when the rate depends on cellular ATP demand) and UNCOUPLED (when the maximum capacity of electron transport system is stimulated by increasing concentrations of the protonophore CCCP) states of ATP synthase, when compared with that in control animals ( Figure 3A ). Under the ROUTINE conditions, PVAT from the thoracic aorta of obese animals showed a significant increase in H 2 O 2 production, measured using Amplex Red, when compared with control animals. Increasing concentrations of CCCP, which accelerates electron transport rates into respiratory chain and decreases the lifetime of intermediates capable of donating electrons towards O 2 ·-formation (Skulachev, 1998) , gradually reduced H 2 O 2 levels in PVAT of both groups of mice. However, in PVAT from obese mice, the additional increase in mitochondrial uncoupling led H 2 O 2 production to the levels observed in the control group in the absence of the uncoupler ( Figure 3B ). Because a reduction in O 2 consumption rate increases the formation of ROS through the mitochondrial respiratory chain, we further investigated the potential contribution of mitochondria-derived H 2 O 2 on vascular dysfunction in obese mice. Vascular reactivity studies demonstrated a significant increase in contractile responses mediated by phenylephrine in CCCP-treated PVAT (+) vessels from control animals ( Figure 3C ), which suggests that basal ROS generation in mitochondria mediates the anti-contractile effects evoked by PVAT. In contrast to the effect of CCCP in control animals, the increased contraction to phenylephrine in PVAT (+) aortic rings from HFD-fed mice was extensively restored by the protonophore CCCP (10 À6 M) ( Figure 3D ). Together, these results indicate that impairment of mitochondrial respiration in obesity increases ROS generation in PVAT and leads to loss of the anti-contractile effects of PVAT.
Loss of the anti-contractile effects of PVAT in HFD-induced obesity is mediated by increased activity of the RhoA/Rho kinase pathway in vascular smooth muscle
The RhoA/Rho kinase pathway plays a critical role in vascular smooth muscle contraction and calcium (Ca 2+ ) sensitization and contributes to the vascular hyperactivity in obesity and hypertension. We examined whether increased mROS in the PVAT induces RhoA/Rho kinase activation in vascular smooth muscle cells. Figure 4A shows that pretreatment of aortic rings with the Rho kinase inhibitor Y-27632 (10 À4 M) decreased contractions to phenylephrine only in PVAT (À) vessels from control mice. However, Y-27632 corrected the increased vasoconstrictor response to phenylephrine in PVAT (À) and PVAT (+) vessels from obese mice ( Figure 4B ). These results point to an important role of the RhoA/Rho kinase pathway in mediating the vascular effects of increased mROS generation in PVAT from obese mice. Phenylephrine-contracted arteries from HFD-fed mice exhibited an increased sensitivity to Rho kinase inhibition compared with control arteries ( Figure 4C ). Rho kinase activity was up-regulated in aortas isolated from obese mice, and PEG-catalase decreased Rho kinase activity ( Figure 4D ). Consistent with the increased RhoA/Rho kinase pathway activation, PVAT from obese mice displayed significant increases in both total ( Figure 4E ) and phosphorylated ( Figure 4F ) MYPT-1, a major Rho kinase target.
TNF-α contributes to increased mitochondrial ROS and mediates the loss of the anti-contractile effects of PVAT in HFD-fed obese mice
The contribution of TNF-α, a major mediator of adipose tissue inflammation, to the raised levels of ROS in PVAT from obese mice, was determined. The TNF-α inhibitor infliximab (10 À4 M) effectively reduced mitochondrial H 2 O 2 levels, evaluated by Amplex Red assay, in PVAT from obese mice. Control isotype (anti-mouse IgG) did not alter PVAT H 2 O 2 production (data not shown). The effects of infliximab were comparable with those evoked by the mitochondrial uncoupler CCCP, and they were not potentiated by concomitant incubation with CCCP, indicating the participation of TNF-α in the increased mROS generation in PVAT from obese mice. Supporting these data, incubation of PVAT from control animals with TNF-α (5 ng·mL À1 ) dramatically increased H 2 O 2 levels, and CCCP attenuated this effect ( Figure 5A ). Aortic rings from control mice incubated with TNF-α displayed increased contractile responses to phenylephrine when compared with respective vehicle-treated control rings. However, the magnitude of this effect was markedly greater in PVAT (+) vessels ( Figure 5B ), supporting the idea that obesity-associated inflammation directly affects PVAT and vascular smooth muscle function.
Furthermore, PVAT from obese mice exhibited increased TNF-α mRNA expression, evaluated by quantitative RT-PCR experiments ( Figure 5C ).
The potential contribution of TNF-α to elevated mROS generation in PVAT of obese mice was further examined using TNF-α receptor deficient mice. As previously mentioned, TNF-α receptor deficient mice exhibited nutritional parameters similar to those observed in wild type mice (Table S2) . However, mice deficient in TNF-α receptors did not exhibit increased blood glucose. There was no significant difference in vascular responses to phenylephrine between mice lacking TNF-α receptors and the control group either in the presence or in the absence of PVAT ( Figure 5D ). However, TNF-α receptor deficiency in obese mice Figure 3 HFD obesity increases mitochondria-derived O 2 .-conversion to H 2 O 2 , which contributes to the loss of the anti-contractile effects of PVAT. Mitochondrial oxygen consumption (A) and (B) H 2 O 2 production (n = 9 in all groups) in PVAT from the thoracic aorta of control and obese animals in the presence of ROUTINE and increasing concentrations of CCCP, a protonophore and mitochondrial uncoupler. Concentration-effect curves to phenylephrine were performed in endothelium-denuded aortic rings from control (C; n = 6 for each experimental group) and obese (D; n = 7 for each experimental group) mice. The role of mROS generation on PVAT modulation of aortic smooth muscle contraction was investigated using CCCP (10 À6 M). Results represent the mean AE SEM. * P < 0.05 versus respective Control; ≠ P < 0.05 versus respective ROUTINE; # P < 0.05 versus Control PVAT (+); & P < 0.05 versus Obese PVAT (+).
BJP R M da Costa et al.
significantly reduced both the sensitivity and the maximal contraction to phenylephrine in PVAT (À) and PVAT (+) aortic rings ( Figure 5E ). After confirming improved PVAT modulation of vascular contraction in obese mice lacking TNF-α receptors, we examined potential mechanisms underlying this effect by evaluating the generation of H 2 O 2 in PVAT from obese TNF-α receptor deficient mice. In these animals, there was a significant decrease in H 2 O 2 levels ( Figure 5F ), indicating that this pro-inflammatory adipokine is a critical mediator of the loss of the anti-contractile effects of PVAT in obesity. Rho kinase activity was up-regulated in aorta isolated from obese mice, and lack of TNF-α receptor decreased Rho kinase activity ( Figure 5G ).
Figure 4
Increased mROS in PVAT from obese mice induces RhoA/Rho kinase activation in vascular smooth muscle cells. Concentration-effect curves to phenylephrine were performed in endothelium-denuded aortic rings from control [(A) n = 7 for each experimental group] and obese [(B) n = 8 for each experimental group] mice. The role of RhoA/Rho kinase pathway on PVAT modulation of aortic smooth muscle contraction was investigated using Y27632 (10 À4 M). Concentration-effect curves to Y27632 (C) were performed in endothelium-denuded aortic rings with or without PVAT (n = 8 for each experimental group); Y27632-induced relaxation was evaluated in phenylephrine (PE)-contracted vessels. In (D), the Rho kinase activity was determined by ELISA in aortas from control and obese mice (n = 5 in both groups). Representative Western blots are shown in the upper panels, with quantitative analysis in the lower panels [(E and F) n = 5 for each experimental group]. Results were normalized to β-actin expression and are expressed as relative units. Representative images were selected from the same membrane. Results represent the mean AE SEM. * P < 0.05 versus Control PVAT (À); π P < 0.05 versus Control PVAT (+); # P < 0.05 versus Obese PVAT (À); & P < 0.05 versus Obese PVAT (+).
As UCP-1 regulates the mitochondrial redox state, UCP-1 protein expression was determined in PVAT of obese animals using Western blot analysis. Obesity reduced UCP-1 protein expression in the PVAT ( Figure 5H ). Consistent with this finding, incubation of PVAT from control mice with TNF-α significantly reduced UCP-1 expression ( Figure 5I ), further supporting our hypothesis that TNF-α is a crucial mediator of increased mROS generation in PVAT from obese mice.
Discussion
The present study describes a previously unknown contribution of mitochondria to PVAT-associated oxidative stress and vascular dysfunction in obesity. HFD-induced obesity increased O 2 .-and H 2 O 2 formation in PVAT by reducing mitochondrial respiration, which might have been due to lower expression of the uncoupling protein UCP-1 and decreased
Figure 5
PVAT-derived TNF-α mediates increased mROS generation and is a critical mediator of the loss of the anti-contractile effects of PVAT in arteries from HFD-fed obese mice. Production of H 2 O 2 by PVAT (A) was examined in the presence of vehicle, CCCP, infliximab and TNF-α, using Amplex Red reagent (n = 7 in all groups). Concentration-effect curves to phenylephrine were performed in aortic rings from control mice incubated with TNF-α (5 ng·mL À1 ) [(B) n = 8 for each experimental group]. TNF-α mRNA expression was assessed by real-time PCR [(C) n = 6 in all groups].
Concentration-effect curves to phenylephrine (PE) were performed in aortic rings from control [(D) n = 8 for each experimental group] and obese [(E) n = 8 for each experimental group] TNF-α receptor-deficient mice. Production of H 2 O 2 by PVAT [(F) n = 7 in all groups]. Rho kinase activity was determined by ELISA in aortas from wild type and TNF receptor deficient mice [(G) n = 5 in both groups]. UCP-1 protein expression in PVAT from HFD-treated mice [(H) n = 6 in both groups] and PVAT from control mice incubated with TNF-α [(I) n = 6 in both groups] was determined by Western blot. Results represent the mean AE SEM. Representative Western blots are shown in the upper panels, with quantitative analysis in the lower panels. Results were normalized to β-actin expression and are expressed as relative units. * P < 0.05 versus Control; # P < 0.05 versus Obese; & P < 0.05 versus Control_TNF-α; $ P < 0.05 versus Control PVAT (À); % P < 0,.05 versus Control PVAT (+); π P < 0.05 versus Obese PVAT (À); ∞ P < 0.05 versus Obese PVAT (+).
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expression of antioxidants, primarily by increasing TNF-α production in the adipocytes. Importantly, these changes are associated with increased activation of the RhoA/Rho kinase pathway in vascular smooth muscle cells, which further contributes to obesity-associated vascular dysfunction.
Although most of the published experiments have used mesenteric vessels, the role of aortic PVAT in human vascular disease is becoming increasingly apparent. The Framingham Heart Study recently reported that high levels of thoracic PVAT is significantly associated with a higher prevalence of cardiovascular diseases, even in individuals without high levels of visceral adipose tissue (Britton et al., 2012) . Of importance, the activation of thermogenesis in thoracic aorta PVAT is accompanied by attenuation of atherosclerosis in apolipoprotein E deficient mice (ApoE), whereas this protection is lost in mice where the PVAT is absent (Chang et al., 2012) . Clearly, the emerging data from these studies compel us to better understand the effects of aortic PVAT on vascular pathophysiology.
Perivascular fat regulates vascular tone through the release of vasoactive mediators (Löhn et al., 2002; Gollasch and Dubrovska, 2004) . Impairment of this ability has detrimental effects on the vascular system. Our data support a defective PVAT modulation of vascular contraction in obesity, as the physiological anti-contractile properties of PVAT in response to adrenergic stimulation were abolished, leading to higher maximal contractions in obese mice. Our findings are consistent with previous studies showing impaired PVAT-mediated vasodilation in obese mice (Marchesi et al., 2009) and increased PVAT-mediated contractile effects in coronary arteries from obese pigs (Owen et al., 2013) .
Two main mechanisms mediate the vascular effects of PVAT: an endothelium-dependent pathway involving release of NO and an endothelium-independent pathway involving release of H 2 O 2 (Gao et al., 2007; Spradley et al., 2015 Continued) in the presence of tiron. Consistent with this finding, ROS generation was substantially increased in PVAT from the thoracic aorta of obese mice, suggesting that H 2 O 2 , formed via SOD from O 2 .-, acts as a signalling molecule activating redoxsensitive pathways, contributing to the loss of the anticontractile effects of PVAT. Under conditions of oxidative stress, the body has compensatory mechanisms that decrease or increase local free radical production. This mechanism may explain the absence of antioxidant effects in PVATdenuded vessels, indicating that, in the presence of periaortic fat, mitochondria play a major role in ROS production. Obesity is associated with mitochondrial dysfunction, including abnormalities in mitochondrial fission and fusion, impaired mitochondrial biogenesis (Zorzano et al., 2009) , inflammation and oxidative stress (Martínez, 2006) . Importantly, mitochondrial membrane depolarization, through mROS-dependent and independent mechanisms, plays a pivotal role in vascular biology. Considering the presence of large numbers of mitochondria and the relatively lower oxygen consumption in PVAT (Greenstein et al., 2009; Fitzgibbons et al., 2011; Chang et al., 2012; Padilla et al., 2013) , we hypothesized that the mitochondrial electron transport chain played a key role as the major location of O 2 .-generation in PVAT, which was then converted to H 2 O 2 by the enzyme SOD. In fact, ROS production in PVAT is controlled by the activity of the mitochondrial electron transport system, which explains the severe decrease in the rate of O 2 consumption concurrent with the highest rate of ROS production in PVAT from HFD-fed mice when compared with that in control animals. When the electron transport system was accelerated in PVAT from obese animals, H 2 O 2 production was reduced to levels observed in the PVAT of control animals, and contractions to phenylephrine in PVAT-intact vessels from obese mice were restored. Changes in the number of mitochondria may underlie cellular responses related to hypoxia, oxidative stress and apoptosis (Martínez, 2006) . However, there was no difference in the expression of respiratory complex proteins in PVAT from control and obese mice ( Figure S1 ), indicating a similar number of mitochondria. (Silva et al., 2013; García-Redondo et al., 2015) . Obesity also favours increased activity of the RhoA/Rho kinase pathway, promoting cardiac dysfunction, loss of endothelium-dependent relaxation, increased intracellular Ca 2+ and subsequent vascular hypercontractility (Nishimatsu et al., 2005; Naik et al., 2006; Schinzari et al., 2012; Soliman et al., 2015) . The RhoA/Rho kinase pathway is a potential contributor to the mechanism by which a higher output of mitochondrial H 2 O 2 , derived from PVAT, increased vascular contraction in obese mice. Indeed, the Rho kinase inhibitor Y-27632 blocked the increased contractions to phenylephrine in PVAT-intact vessels from obese mice, an effect that was abolished by PVAT removal. The relaxation induced by Y27632 provided additional evidence that PVAT increased RhoA/Rho kinase activity, as aortas from HFD-fed mice displayed increased sensitivity to Y-27632-induced relaxation. The involvement of the RhoA/Rho kinase pathway in vascular dysfunction has also been demonstrated in resistance and conductance arteries of hypertensive animals (Weber and Webb, 2001; Asano and Nomura, 2003) . Our data show that the presence of PEG-catalase reduced Rho kinase activity, strengthening the hypothesis that mROS modulate the RhoA/Rho kinase pathway. ROS generation stimulates Rho translocation and Rho kinase activation, which leads to inhibition of MLC phosphatase, resulting in smooth muscle contraction in endothelium-denuded rat aorta (Jin et al., 2004) . In addition, our data showed that phosphorylation of MYPT-1, an important Rho kinase target, was increased in PVAT-intact aortas from obese mice. To our knowledge, this is the first study demonstrating a direct interaction between PVAT and RhoA/Rho kinase signalling in vascular smooth muscle. The presence of inflammation, imbalanced production of adipokines and oxidative stress in PVAT has been linked to increased vasoconstriction and vascular dysfunction in obesity (Chen et al., 2010; Morgan and Liu, 2010; Szasz et al., 2013; Anusree et al., 2015) . PVAT dysfunction in obese pigs has been associated with marked alterations in the proteome profile of the coronary PVAT (Owen et al., 2013) . Moreover, reduction in adiponectin production by PVAT and the consequent reduction in the opening of Ca 2+ activated K + channels (BK Ca ) in smooth muscle has been associated with impaired relaxation of mesenteric arteries in ob/ob mice (Agabiti-Rosei et al., 2014) . Adiponectin negatively modulates cardiovascular inflammation, and reduced adiponectin levels in obesity are associated with increased levels of TNF-α (Nishimura et al., 2006) and, possibly, with TNF-α-induced deleterious effects. In this study, we focused on the role of TNF-α to promote mitochondrial oxidative stress in the PVAT but have not addressed the possibility that a decrease in adiponectin levels may account for the effects of TNF-α, which certainly deserves to be investigated. We have provided evidence that the inflammatory adipokine TNF-α modulated mitochondrial homeostasis in PVAT. Accordingly, TNF-α increased H 2 O 2 generation by the mitochondrial electron transport chain in PVAT, and the TNF-α inhibitor infliximab reduced H 2 O 2 generation in PVAT from obese mice. These observations are in agreement with a recent report showing that epithelial cells stimulated with TNF-α exhibit reduced oxygen consumption and increased mROS generation (Babu et al., 2015) . Of importance, TNF-α receptor deficient, obese mice did not exhibit PVAT dysfunction, that is, the anti-contractile effects of PVAT were preserved. In order to offer a better view of the status of the RhoA/Rho kinase pathway, we determined Rho kinase activity in vessels from TNF-α receptor deficient mice and found a significant decrease in Rho kinase activity in aortas from these mice. This finding provides a link between the Rho kinase pathway, PVAT and inflammation, all contributors to obesity-associated vascular function.
TNF-α may alter PVAT mitochondrial respiration by decreasing the uncoupling pathways in the inner mitochondrial membrane, like that promoted by UCP. As protonophores, UCPs promote dissipation of the proton gradient, stimulating electron flux and respiration. Consistent with this hypothesis, TNF-α significantly decreased UCP-1 expression in PVAT. Although the mechanism involved in this effect has not been elucidated in this study, TNF-α-induced reduction in UCP-1 has been demonstrated in adipocytes from brown fat (Masaki et al., 1999; Valladares et al., 2001) .
There is functional similarity between the PVAT and BAT, and obese individuals exhibit functional loss of both tissues. Recent studies have shown that increased body mass produces 'whitening' of BAT, reduces β-adrenoceptor signalling, favours the presence of unilocular lipids and produces marked mitochondrial dysfunction (Shimizu and Walsh, 2015) . The exact mechanisms that lead to BAT damage in obesity are not completely elucidated, but it is known that the whitening effect promotes infiltration of immune cells and increases production of proinflammatory cytokines. These events corroborate data from the present study, reinforcing an association between obesity, inflammation and mitochondrial dysfunction.
In summary, this study presents evidence that TNF-α-induced oxidative stress is a key mechanism involved in the loss of the anti-contractile effects of PVAT. Moreover, we describe a previously unknown contribution of mitochondria to increased O 2 .-generation and its conversion to H 2 O 2 in PVAT. Notably, these changes are associated with increased activation of the RhoA/Rho kinase pathway in vascular smooth muscle cells, leading to vascular dysfunction in obesity.
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